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Abnormalities in the NC! domain of collagen type IV in GBM in canine
hereditary nephritis. Samoyed hereditary glomerulopathy (SHG) in
dogs serves as a model for human X-linked hereditary nephritis (HN).
We previously showed that glomerular capillaries of affected males did
not stain by immunofluorescence (IF) using serum from a patient with
Goodpasture's syndrome. Our goal in the present study was to deter-
mine whether the NCI domain of the collagen type IV molecule, which
contains Goodpasture antigen (GPA), could be demonstrated in these
dogs, and to assess its immunological reactivity. By SDS-PAGE, NCI
in collagenase digests of glomerular basement membranes (GBM) of
unaffected and carrier female dogs in the family with SHG showed 24
kilodalton (kD), 26 kD and 28 kD monomer, and 46 kD and 47 kD dimer
components, but the 24 kD monomer was diminished in the affected
males. By IF, a rabbit antibody to NC I stained glomerular capillaries of
unaffected, affected male, and carrier female dogs. In contrast, a human
anti-GBM plasmapheresis fluid (PPF) stained glomerular capillaries of
only the unaffected and carrier female dogs. By RIA, both antibodies
reacted strongly with NCI in collagenase digests of GBM of the
unaffected and carrier female dogs, but showed reduced reactivity with
NCI of affected males. By Western blotting, both antibodies bound to
dimers and 24 kD and 26 kD monomers of the NCI domain in
collagenase digests of GBM of unaffected and carrier female dogs.
However, in affected males, the rabbit anti-NC I antibody did not bind
to the 24 kD monomer, while the human anti-GBM PPF showed weak
binding to the 24 kD and 26 kD monomers. Hence, although the NCI
domain could be detected in GBM of affected male dogs, a reduced
amount of the 24 kD monomer was present and, as well, the 26 kD
monomer possessed altered immunological reactivity. These two mono-
mers are known to be derived from separate autosomal gene products in
man. Hence, our studies raise the possibility that, in SHG and X-linked
HN, the underlying defect may involve a protein which is coded on the
X chromosome and is involved in modifying the collagen type IV
molecule.
Hereditary nephritis (HN) is an inherited glomerular disease,
often associated with extrarenal manifestations including deaf-
ness (Alport's syndrome) and anterior lenticonus [1, 2]. Most
patients present with hematuria and later develop proteinuria.
Males usually progress to end-stage renal disease, whereas
females show a variable outcome, ranging from unimpaired
renal function to renal failure. Widespread multilaminar split-
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ting of glomerular capillary basement membranes is seen by
electron microscopy (EM) [l—4].
Recent insight into the pathogenesis of HN has arisen from
studies utilizing immunofluorescence (IF) microscopy per-
formed on renal biopsies of patients with HN. When these were
examined using serum obtained from patients with Good-
pasture's syndrome, glomerular capillaries of most males and
some females with HN failed to stain, while staining was seen in
healthy subjects and patients with glomerular diseases other
than HN [5—8]. It has been proposed that a constituent of
glomerular capillaries, referred to as Goodpasture antigen
(GPA), is lacking in HN patients and that it plays a role in the
development of HN. However, further studies on pathogenesis
have been hindered by the absence of a suitable animal model
for HN.
We previously described the clinical, genetic, and morpho-
logic features of a spontaneously occurring renal disease in a
family of Samoyed dogs, termed Samoyed hereditary glomeru-
lopathy (SHG), which closely resembles HN in man [9—121. In
these studies, the gene for SHG was shown to be inherited in an
X-linked dominant fashion [9], so that males with SHG develop
severe renal disease and females show only mild renal impair-
ment [12]. By EM, glomerular capillary basement membranes
of affected males demonstrate extensive multilaminar splitting,
identical to that in human HN, while carrier females show only
segmental areas of splitting [10]. Moreover, glomerular capil-
larie of affected male dogs did not stain by IF using serum from
a patient with Goodpasture's syndrome that cross reacted with
normal dog kidney, implying that GPA was absent or immuno-
logically altered [11]. In the present study, the NC1 domain of
the collagen type IV molecule, which contains GPA, could be
demonstrated by SDS-PAGE in collagenase digests of glomer-
ular basement membranes (GBM), not only of unaffected and
carrier female dogs in the pedigree with SHG, but also of
affected males. However, the 24 kilodalton (kD) component of
NC1 in GBM of affected male dogs was diminished in amount,
as assessed by SDS-PAGE. Furthermore, the 26 kD component
showed altered immunological reactivity, as assessed by West-
ern blotting. These findings have allowed us to speculate on the
pathogenesis of human HN.
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Methods
Class jfication of Samoyed dogs
Offspring of carrier females in a family with SHG were
sacrificed at five months of age. Kidneys were removed and
stored at —20°C until used for extraction of NC1 from GBM.
Portions of kidneys of the Samoyed dogs were also fixed in 4%
paraformaldehyde-l% glutaraldehyde and processed for EM.
The Samoyed dogs were classified as unaffected, affected
males, or carrier females on the basis of the EM appearance of
their glomerular capillary basement membranes (that is, normal
in unaffected dogs, extensive multilaminar splitting in affected
males and segmental multilaminar splitting in carrier females)
[10]. Based on this study, the kidneys were pooled into three
groups.
Preparation of collagenase digests of GBM
Glomeruli were obtained by graded sieving, as previously
described [131, from the kidneys of adult mixed breed dogs at
the time of sacrifice following experimental cardiovascular
surgery, from the Samoyed dogs, and from humans 3 to 17
years of age at the time of post-mortem examination. Briefly,
portions of renal cortex were forced through a 115 mesh
stainless steel sieve (WS Tyler, St. Catharines, Ontario, Can-
ada) and suspended in normal saline. The suspension was then
passed through an 80 mesh sieve seated above a 150 mesh sieve.
Glomeruli were collected from the 150 mesh sieve, washed in
normal saline followed by distilled water and centrifuged into a
pellet. The pellet was suspended in I M NaCI and sonicated
until it no longer contained cellular components but consisted
only of GBM, as assessed by light microscopy. The sonicate
was washed five times with 1 M NaCI, five times with distilled
water, centrifuged into a pellet, and lyophilized. The sonicate
was then weighed and suspended at a concentration of 5 mg/ml
in 0.05 M HEPES buffer, pH 7.5, containing 1 mrvi phenylmeth-
anesulphonylfluoride and 0.01 M CaCl2. Bacterial collagenase
type VII (Sigma Chemical Co., St. Louis, Missouri, USA) was
added (10 U/mg GBM) and incubation was carried out for 72
hours at 37°C with constant agitation. The preparation was then
centrifuged for one hour at 100,000 g and the supernatant was
precipitated overnight by adding a tenfold volume of 95%
ethanol. The precipitate was centrifuged into a pellet, air dried,
and stored at —20°C.
Rabbit and human antibodies
Rabbit anti-NCJ antiserum. A collagenase digest was pre-
pared from GBM of mixed breed dogs and was subjected to
SDS-PAGE. The gel was stained with Coomassie Brilliant Blue,
the NCI dimer and monomer bands were cut out, pooled,
destained with ethanol, crushed, and emulsified in complete
Freund' adjuvant. A rabbit was injected subcutaneously at
monthly intervals with 1 mg of this preparation and bled after
the third injection. This reagent has been referred to as 'rabbit
anti-NC1 antiserum' in the present study.
Human anti-GBM plasmapheresis fluid (PPF). PPF contain-
ing antibody to human GBM that cross reacted with dog
glomerular capillaries, as assessed by IF, was obtained from a
patient with anti-GBM nephritis who was being treated by
plasmapheresis. It has been referred to in this study as 'human
anti-GBM PPF'.
IF microscopy
Tissue sections of kidney were snap frozen in liquid nitrogen,
stored at —70°C, and cut at 5 ,a on a cryostat. The sections were
picked up on gelatinized slides, treated with rabbit anti-NC 1
antiserum (1:20 dilution) or human anti-GBM PPF (1:3 dilu-
tion) and stained using either fluoresceinated goat anti-rabbit
(Miles, Naperville, Illinois, USA) or rabbit anti-human (Calbio-
chem, San Diego, California, USA) IgG antisera. In some
experiments, before the rabbit antiserum or human PPF and
fluoresceinated conjugates were applied, the tissue sections of
kidney were first treated for two hours with acid urea (AU) (6 M
urea, 0.1 M glycine-HC1, pH 3.5) to expose hidden NC1, as
previously described [14]. Normal rabbit serum and PPF ob-
tained from a patient being treated for familial hypercholester-
olemia were used as negative controls.
SDS-PAGE
SDS-PAGE was performed according to the method of
Laemmli [151, using SDS-containing 5% stacking and 8 to 18%
gradient running polyacrylamide slab gels. Fifty tg of collage-
nase digest were applied to each lane and the gels were stained
with Coomassie Brilliant Blue. Standards (Sigma) used to
calculate molecular weights included phosphorylase B (92.5
kD), bovine serum albumin (69 kD), ovalbumin (46 kD), car-
bonic anhydrase (30 kD), soybean trypsin inhibitor (21.5 kD)
and lysozyme (14.3 kD).
Western blotting
Western blotting was performed according to the method of
Towbin, Staehelin and Gordon [16]. Gels were subjected to
SDS-PAGE, using 25 of collagenase digest in each lane, and
the separated components were transferred to nitrocellulose
paper at 25 volts for 18 hours using a Trans-blot cell (Biorad,
Richmond, California, USA). The blots were then incubated for
six hours in 3% bovine serum albumin in Tris buffered saline,
pH 7.4, and overnight in a 1: 100 dilution of rabbit anti-NC 1
antiserum or a 1:50 dilution of human anti-GBM PPF. The blots
were rinsed and incubated for five hours with 106 cpm 1125
protein A, exposed to X-ray film and developed.
Plate-binding RIA
The rabbit anti-NC 1 antiserum and human anti-GBM PPF
were tested in a plate-binding RIA for reactivity against dog
NC1, laminin, and collagen type IV. Negative controls were the
normal rabbit serum and PPF used in the IF experiments.
Rabbit anti-laminin antiserum was obtained from Bethesda
Research Lab (Gaithersburg, Maryland, USA), while rabbit
anti-collagen type IV antiserum was prepared by us by immu-
nizing rabbits with triple-helical collagen type IV extracted
from human placenta by pepsin digestion [17]. Laminin was
obtained from Bethesda Research Lab, collagen type IV was
prepared from a pepsin digest of placenta and obtained from
Calbiochem (San Diego, California, USA), and NCI was pre-
pared by us by collagenase digestion of GBM. Wells of dispos-
able flexible microtiter plates (Limbro 76-364-05, Flow Labora-
tories, McLean, Virginia, USA) were coated for two hours at
37°C with 100 pi of the various substrates (10 sg/ml) plated in
0.02 M phosphate-buffered saline (PBS) (145 msi NaCI, 9 msi
NaH2PO4, 11 mri Na2HPO4, pH 7.2) or AU. The substrates
Analysis by SDS-PAGE of NC! domain in co/la genase
digests of GBM of humans, mixed breed dogs
and Samoyed dogs
By SDS-PAGE, the NC! domain in collagenase digests of
GBM of humans showed monomer bands at 24 kD, 26 kD and
28 kD, and dimer bands at 46 kD and 48 kD (Fig. 1A). The
pattern of NC! obtained from GBM of mixed breed dogs was
similar except that the dimer bands were at 46 kD and 47 kD
(Fig. 1B). By SDS-PAGE, NC! in collagenase digests of GBM
of unaffected and carrier female dogs of the pedigree with SHG
showed similar bands to those seen in the mixed breed dogs
(Fig. 2A,C). However, in the affected males, there was a
diminution in the amount of the 24 kD monomer band (Fig. 2B).
Characterization of the rabbit and human antibodies
Rabbit anti-NCJ antiserum. By IF, the rabbit anti-NC1
antiserum failed to stain glomerular capillaries on tissue sec-
tions of normal dog kidney before treatment with AU. How-
ever, following AU, strong staining was observed, indicating
that this antiserum detected hidden NC! determinants (Fig. 4).
Using the RIA, this antiserum reacted only weakly with NC!
obtained from GBM of mixed breed dogs when the NC! was
plated in PBS, but reactivity was markedly enhanced when the
NC1 was plated in AU (Fig. 3A). The rabbit anti-NC 1 antiserum
did not react by RIA with laminin (Fig. 3B) or collagen type IV
(data not shown). In the case of laminin and collagen type IV,
no enhancement of binding was observed when these substrates
were plated in AU prior to reaction with their respective
antisera (data not shown). By Western blotting, the rabbit
anti-NC 1 antiserum bound to the dimer and 26 kD monomer
Fig. 1. SDS-PAGE and Western blotting of
NC! in collagenase digests of GBM of humans
and mixed breed dogs. In a first experiment, 50
g samples of collagenase digest of GBM of (A)
humans and (B) mixed breed dogs were
examined by SDS-PAGE, as outlined in
Methods. The gel was stained with Coomassie
Brilliant Blue. Molecular weights of standards
are shown at the left. In a second experiment,
25 g samples of human (C and E) and dog (D
and F) collagenase digest were subjected to
SDS-PAGE, then transferred to nitrocellulose
(Western blotting) and developed using rabbit
anti-NC! antiserum (C and D) or human anti-
GBM-PPF (E and F), as outlined in Methods.
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Fig. 2. SDS-PAGE of5O p.g samples of collagenase digests of GBM of
unaffected (A), affected male (B), and carrier female (C) Sainoyed
dogs. SDS-PAGE was performed as outlined in Methods. The gel was
stained with Coomassie Brilliant Blue. Molecular weights of standards
are shown at the left.
components of human NC! (Fig. 1C) and to the dimer and 24
kD and 26 kD components of dog NC! (Fig. 1D).
Human anti-GBM PPF. By IF, the human anti-GBM PPF
also showed no staining of glomerular capillaries before, but
strong staining after, treatment of tissue sections of norma! dog
kidney with AU, indicating that it detected hidden NC1 deter-
minants (Fig. 4). By RIA, the PPF reacted with dog NC!, but
only when the Nd was plated in AU (Fig. 3C). No reactivity
by RIA was seen with laminin or collagen type IV (data not
shown). By Western blotting, binding to the dimer and all three
monomer components of human NC1 was seen (Fig. 1E). The
strongest binding was to the 28 kD monomer, with intermediat
binding to the 26 kD monomer, and only weak binding to the 24
kD monomer. With dog NC1, binding to the dimers and 24 kD
and 26 kD monomers was observed, with stronger binding to
the 24 kD than to the 26 kD monomer (Fig. iF).
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were then removed. The wells were washed three times with
PBS and flooded with 10% fetal calf serum for two hours at
37°C, after which the fetal calf serum was removed and the
wells were again rinsed three times with PBS. Then, 100 .d
dilutions of the rabbit anti-NC 1 antiserum or human anti-GBM
PPF was added to the wells and the plates were incubated for 16
hours at 4°C, at which time these reagents were removed and
the wells were washed three times with PBS. Finally, 100 sl of
1125 protein A (Amersham, Arlington Heights, Illinois, USA),
containing 20,000 cpm, was added to the wells for two hours at
room temperature. The wells were washed three times with
PBS, cut out and counted on a Beckman 300 gamma counter.
Results
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Dilution (1/2°)
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Laminin in PBS; rabbit anti-NC1 •)
Laminin in PBS; rabbit anti-laminin (0)
Laminin in PBS; NAS (0)
Dilution (1/2°)
Symbols are:
NC1 in acid-urea; human anti-GBM PPF (•)
NC1 in PBS; human anti-GBM PPF (0)
NC1 in acid-urea; control PPF (U)
NC1 in PBS; control PPF (0)
Characterization of immunological reactivity of NC] domain
in tissue sections of kidney and collagenase digests of GBM
of Samoyed dogs
IF microscopy. With the rabbit anti-NC! antiserum, no
staining of glomerular capillaries of any of the Samoyed dogs
was seen before treatment of tissue sections of kidney with AU
(Fig. 4A). Following AU, staining was seen in unaffected (Fig.
4B), affected male (Fig. 4C) and carrier female dogs. In the case
of the human anti-GBM PPF, there was also no staining of
glomerular capillaries of unaffected (Fig. 4D), affected male, or
carrier female dogs before treatment with AU. However, fol-
lowing AU, glomerular capillaries of unaffected (Fig. 4E) and
carrier female dogs became positive, but those of affected males
remained negative (Fig. 4F).
Plate-binding RIA. The rabbit anti-NCI antiserum reacted
strongly with NC! in collagenase digests of GBM of unaffected
and carrier female Samoyed dogs, especially when the NC1 was
plated in AU (Fig. 5A—C). Reactivity was somewhat diminished
with NC! in GBM of affected males. In the case of the human
anti-GBM PPF, reactivity with NC! was seen only after treat-
ment with AU. Strong reactivity was detected with the NC1 of
unaffected and carrier female dogs, but only weak reactivity
was seen with NC! of affected male dogs (Fig. 5D—F).
Western blotting, By Western blotting, the rabbit anti-NC 1
antiserum bound to the dimer and 24 kD and 26 kD monomer
components of NC1 in collagenase digests of GBM of unaf-
fected (Fig. 6A) and carrier female (Fig. 6C) Samoyed dogs.
Similar results were seen with the affected males, except that no
binding to the 24 kD component of NC! was observed (Fig. 6B).
The human anti-GBM PPF bound strongly to the dimer and 24
kD and 26 kD monomer components of NC1 in collagenase
digests of GBM of unaffected (Fig. 6D) and carrier female (Fig.
6F) dogs, but only weakly to the 24 kD and 26 kD monomer
components of affected male dogs (Fig. 6E).
Discussion
Collagen type IV is composed of four domains: a main triple
helix, a separate triple helix at the N-terminal end, referred to
as the 7S domain, and two non-collagenous (NC) regions. Of
these, the NC2 region joins the two triple helical portions, while
the NC 1 region is located at the C-terminal end of the molecule
[18—23]. The NC! domain obtained by collagenase digestion has
been isolated and found to contain GPA, as demonstrated by its
reactivity with serum obtained from patients with Good-
pasture's syndrome [18, 22—241. NC 1 has a molecular weight of
about 170K [22, 25] and is a hexamer, with contributions from
both the csl(IV) and a2(IV) chains of collagen type IV [22, 25—
271 and possibly from additional chains [27]. Following dena-
turation, NC! dissociates into dimers and monomers, which are
homologous in amino acid composition, and yields the two sets
of bands by SDS-PAGE [241.
We initially characterized NC1 in collagenase digests of GBM
of mixed breed dogs before turning to the family of dogs with
SHG. Previous studies in the literature have utilized mainly
human and bovine material, and data are not available on dogs.
SDS-PAGE of non-reduced collagenase digests of human and
bovine GBM has revealed bands in the region of 48 to 54 kD and
22 to 30 kD [23—26]. However, the size and number of bands
have varied in different studies, depending on the starting
material and the conditions of electrophoresis. It has recently
been reported that NC! isolated from human GBM under
non-reducing conditions could be resolved into three bands in
the lower molecular weight region, located at 24 kD, 26 kD, and
28 kD [28, 29]. Dog NC 1 was compared with human NC 1 using
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Fig. 3. Plate binding radioimmunoassay, showing reactivity of rabbit antiserum to NC! with (A) dog NC! and (B) laminin, and reactivity of
human anti-GBM PPF with (C) dog NCJ. Wells of microtiter plates were coated with a collagenase digest obtained from dog GBM (dog NC 1) or
laminin, followed by rabbit antiserum (A and B) or human PPF (C), and !125 protein A, as outlined in Methods. Collagenase digest was plated either
in acid urea or PBS, while laminin was plated only in PBS.
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Fig. 4. Immunofluorescence (IF) microscopy of glomeruli of unaffected (a,b,d,e) and affected male Samoyed dogs (c,f) using rabbit anti-NCI
antiserum (a,b,c) and human anti-GBM PPF (d,e,f). IF microscopy was performed, as described in Methods, using tissue sections which were
either not pretreated with acid urea (a,d) or pretreated with acid urea to expose hidden Nd determinants (b,c,e,f). (x 300).
these designated molecular weights. In this respect, dog NC1
obtained from GBM resembled human NC! by SDS-PAGE,
except for a 47 kD instead of a 48 kD dimer band.
Both of the antibodies used in this study were characterized
by IF, using tissue sections of kidney of mixed breed dogs, and
by RIA and Western blotting, using NC1 obtained by collage-
nase digestion of GBM of these dogs. Although both produced
staining of glomerular capillaries by IF, staining was evident
only after treatment of the tissue sections with AU, indicating
that the antibodies detected hidden NC1 determinants [141.
Moreover, these antibodies reacted by RIA with dog NC I
obtained from GBM. Reactivity was enhanced by plating in
AU, in the case of the rabbit anti-NC I antiserum, and observed
only in the presence of AU, in the case of the human anti-GBM
PPF. Finally, by Western blotting, both reagents bound to the
24 kD and 26 kD components of dog Nd. In this respect, they
differed in their binding to human NC 1, in which the rabbit
anti-NC 1 antiserum bound only to the 26 kD monomer; and the
human anti-GBM PPF bound to all three monomers, but mainly
to the 28 kD monomer. Western blotting using serum from
patients with Goodpasture's syndrome has been performed by
many investigators on NC1 isolated from normal human GBM
[23, 25, 30, 31]. GPA reactivity has been shown to reside within
the 28 kD monomer of human NC1 [28, 291. The inability of
both of our anti-NC 1 antibodies to bind to the 28 kD monomer
of dog NC1 means that they are not useful for assessing the
immunological reactivity of this monomer in the family of dogs
with SHG. As well, these data imply that the 28 kD bands of
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Fig. 5. Plate binding radioimmunoassay,
showing reactivity of rabbit anti-NC!
antiserum and human anti-GBM PPF with
NC! in collagenase digests of GBM of
unaffected (A,D), affected male (B,E), and
carrier female (C,F) Samoyed dogs. Wells of
microtiter plates were coated with the
collagenase digests, plated in either acid urea
or PBS, followed by rabbit anti.NC1
antiserum (A,B and C) or human anti-GBM
PPF (D,E and F) and V25 protein A, as
outlined in Methods.
human and dog are not equivalent. This view has been rein-
forced by the observation that the strongest binding by human
anti-GBM PPF to human NC1 was to the 28 kD band, whereas
in dog Nd, the strongest binding was to the 24 kD band. The
24 kD band in dog Nd may be equivalent to the 28 kD band in
human Nd, and thus may contain GPA.
Studies were next performed on NC 1 in collagenase digests
of GBM of dogs in the SHG pedigree. Similar 24 kD, 26 kD and
28 kD monomer and 46 kD and 47 kD dimer bands were
detected by SDS-PAGE in collagenase digests of unaffected and
carrier female dogs. NC! could also be isolated from GBM of
affected males, but it differed in that the 24 kD monomer was
diminished in amount. Examination ofNCl in GBM of patients
with the X-linked form of HN by SDS-PAGE has demonstrated
a loss of the 28 kD band [32]. Hence, it would appear that
different defects in the NC1 domain are present in SHG in dogs
and HN in man. However, if the 28 kD human band is the
equivalent of the 24 kD dog band, as mentioned above, then the
defect in the NC! domain may actually be similar in SHG and
HN.
In addition to the abnormality demonstrated by SDS-PAGE,
a further difference in the NC! domain in collagenase digests of
GBM of affected male dogs was demonstrated on the basis of
immunological reactivity, using IF, RIA, and Western blotting.
Glomerular capillaries of affected male dogs failed to stain by IF
with the human anti-GBM PPF, and NC1 obtained from GBM
of these dogs reacted by RIA only poorly with the human
anti-GBM PPF. Moreover, the 24 kD monomer of NC1 in
collagenase digests of GBM of affected male dogs failed to bind
to the rabbit anti-NC! antiserum by Western blotting, while the
24 kD and 26 kD monomers bound only weakly to the human
anti-GBM PPF. Although the decreased binding by both these
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Fig. 6. Western blotting of 25 ,.tg samples of
collagenase digests of GBM of unaffected
(A,D), affected male (B,E), and carrier female
(C,F) Samoyed dogs. Collagenase digests
were analyzed by SDS-PAGE, transferred to
nitrocellulose (Western blotting) and
developed using rabbit anti-NC! antiserum
(A,B,C) or human anti-GBM PPF (D,E,F), as
outlined in Methods.
antibodies to the 24 kD component could be attributed to a
reduced amount of this monomer, as demonstrated by SDS-
PAGE, these observations suggest that the NC1 domain in
collagenase digests of GBM of affected males was immunolog-
ically altered in its 26 kD monomer component. A defect in the
28 kD monomer of NC1 of affected male dogs could not be
excluded, since neither of the two anti-NC 1 reagents used in the
present study reacted with 28 kD monomer. Using 2-D gel
electrophoresis and Western blotting of normal human GBM,
the greatest binding of serum from patients with Goodpasture's
syndrome was to the cationic proteins of NC! [28, 31], partic-
ularly to the cationic 28 kD subunit [28], with weaker binding to
the 24 kD, 26 kD, and non-cationic 28 kD subunits ofNCl. Both
the cationic and non-cationic 28 kD components have been
reported to be absent from GBM of patients with HN [32].
Some patients with HN who have undergone renal transplan-
tation have developed anti-GBM antibodies, which, by IF,
bound to glomerular capillaries [33]. However, serum from a
patient with I-IN who developed anti-GBM nephritis following
renal transplantation showed binding to the 26 kD but not to the
28 kD component of NCI [34]. Nevertheless, another such
serum showed binding to the 28 kD band [32]. All of the
foregoing results suggest that the abnormality in HN could
involve either the 26 kD or 28 kD monomer components of
NC I. Our results of SDS-PAGE and Western blotting of NC 1 in
GBM of affected male dogs with SHG suggest that both the 24
kD and 26 kD components are abnormal.
Considerable work has been done to elucidate the molecular
nature of the NCI domain using human and bovine material.
The dimer and monomer bands seen by SDS-PAGE are derived
from both the al(IV) and a2(IV) chains of collagen type IV [22,
25—27, 30, 35]. Specifically, the monomer bands seen at 26 kD
and 24 kD are derived from the al(IV) and a2(IV) chains,
respectively. A third monomer, with a molecular weight of
about 28 kD, has also been recovered; its source is unknown,
but it may be a third chain of collagen type IV or a post-
translational modification product of the csl(IV) or a2(IV)
chains [25—29]. The genes for both the al(IV) and c2(IV) chains
have been localized to chromosome 13 in man [36, 37], rather
than to the X chromosome, on which the SHG gene and the
gene for X-linked HN are located [1, 2]. Since, at least in man,
the 24 kD and 26 kD monomers are derived from separate
autosomal gene products, it is difficult to reconcile the existence
of abnormalities in both these monomers, as seen in SHG, with
a single structural gene defect. Rather, our results suggest the
possibility that there is a defect in a protein coded on the X
chromosome which is involved in modifying both these mono-
mers. A defect in an enzyme modifying collagen type IV has
also been postulated as a possible mechanism underlying hu-
man HN [32]. Further work is being carried out to investigate
this hypothesis, and to establish whether there is a role for a
third type of collagen type IV chain in SHG. It is still possible
that different defects underlie SHG and HN but produce the
same result, namely, a disturbance of the function of the NC!
domain. The NC1 region is involved in the initiation of triple
helix formation of the collagen type IV molecule [19] and in the
cross linking of collagen type IV molecules in the supramolec-
ular assembly of basement membranes [20, 22, 23, 38]. A defect
in the NC1 domain, whatever its cause, could lead to faulty
GBM, as seen both functionally and ultrastructurally, in dogs
with SHG and patients with HN. However, the exact molecular
basis for the defect remains to be clarified.
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